Retatrutide is a new pharmaceutical in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By stimulating https://steveayvm279959.look4blog.com/74271146/retatrutide-a-promising-new-treatment-for-obesity